...

首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery Discussion

【24h】

Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery Discussion

机译：铂基诱导化疗联合手术治疗恶性胸膜间皮瘤切除修复交叉互补1组和核糖核苷酸还原酶M1作为预后生物标志物的重要性

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Thoracic and Cardiovascular Surgery》 |2015年第6期|共3页
作者
Pass H.; Opitz; Turna A.; Krasna M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词

相似文献

外文文献
中文文献
专利

1. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery Discussion [J] . Pass H., Opitz, Turna A., The Journal of Thoracic and Cardiovascular Surgery . 2015,第6期

机译：铂基诱导化疗联合手术治疗恶性胸膜间皮瘤切除修复交叉互补1组和核糖核苷酸还原酶M1作为预后生物标志物的重要性
2. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery [J] . Frischknecht Lukas, Meerang Mayura, Soltermann Alex, The Journal of Thoracic and Cardiovascular Surgery . 2015,第6期

机译：铂类诱导化疗联合手术治疗恶性胸膜间皮瘤切除修复交叉互补组1和核糖核苷酸还原酶M1作为预后生物标志物的重要性
3. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery [J] . Frischknecht Lukas, Meerang Mayura, Soltermann Alex, The Journal of Thoracic and Cardiovascular Surgery . 2015,第6期

机译：切除修复交叉互补组的重要性和核糖核苷酸还原酶M1作为铂类诱导化疗治疗的恶性胸膜间皮瘤中的预后生物标志物，随后进行手术治疗
4. Predictive and Prognostic Value of Ribonucleotide Reductase Regulatory Subunit M1 and Excision Repair Cross-Complementation Group 1 in Advanced Urothelial Carcinoma (UC) Treated with First-Line Gemcitabine Plus Platinum Combination Chemotherapy [O] . Miso Kim, Ja Hyeon Ku, Cheol Kwak, -1

机译：一线吉西他滨联合铂类联合化疗治疗晚期尿路上皮癌（UC）中核糖核苷酸还原酶调节亚基M1和切除修复交叉互补组1的预测价值和预后价值
5. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery [O] . Frischknecht, Lukas, Meerang, Mayura, Soltermann, Alex, 2015

机译：铂类诱导化疗联合手术治疗恶性胸膜间皮瘤切除修复交叉互补1组和核糖核苷酸还原酶M1作为预后生物标志物的重要性

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号